Cargando…

Are dopamine and serotonin involved in COVID-19 pathophysiology?

Detalles Bibliográficos
Autores principales:	Attademo, L., Bernardini, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asociación Universitaria de Zaragoza para el Progreso de la Psiquiatría y la Salud Mental. Published by Elsevier España, S.L.U. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598536/ https://www.ncbi.nlm.nih.gov/pubmed/33162632 http://dx.doi.org/10.1016/j.ejpsy.2020.10.004

Ejemplares similares

Thrombocytopenia in COVID-19: pathophysiology matters
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Conceptions of the pathophysiology of happy hypoxemia in COVID-19
por: Dhont, Sebastiaan, et al.
Publicado: (2021)

Repurposing Selective Serotonin Reuptake Inhibitors for COVID-19: Rationale and Concerns
por: Navin, Karthick, et al.
Publicado: (2020)

Pathophysiology, clinical assessment, and investigations involving leg ulcers
por: Langer, Vijay
Publicado: (2014)

Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal
por: Assimakopoulos, Stelios F., et al.
Publicado: (2020)

Toward a unified pathophysiology in COVID-19 acute aortopathies
por: Roncati, Luca, et al.
Publicado: (2021)

Misconceptions of pathophysiology of happy hypoxemia and implications for management of COVID-19
por: Tobin, Martin J., et al.
Publicado: (2020)

Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
por: Ilias, Ioannis, et al.
Publicado: (2020)

Takotsubo Syndrome in COVID-19 Requires Elucidation of the Pathophysiological Background
por: Finsterer, Josef, et al.
Publicado: (2022)

COVID-19, liver dysfunction and pathophysiology: A conceptual discussion
por: Gonçalves Júnior, Jucier
Publicado: (2022)

Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: author's response
por: Deng, Jiawen, et al.
Publicado: (2023)

Presentation and pathophysiology of neuro-COVID
por: Finsterer, Josef, et al.
Publicado: (2021)

Kleptomania: Beyond serotonin
por: Mangot, Ajish G.
Publicado: (2014)

Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters
por: Hagino, Y, et al.
Publicado: (2011)

Response to ‘Presentation and pathophysiology of neuro-COVID’
por: Orsucci, Daniele, et al.
Publicado: (2021)

Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
por: Magoon, Rohan, et al.
Publicado: (2021)

Altered microRNA expression in severe COVID‐19: Potential prognostic and pathophysiological role
por: Garnier, Nathalie, et al.
Publicado: (2022)

Post COVID‐19 condition: critical need for a clear definition and detailed pathophysiology
por: Kerkhoff, Tom J., et al.
Publicado: (2022)

Commentary: Barotrauma in critically ill patients with COVID-19: miles to go to unwrap the pathophysiology
por: Bhattacharya, Dipasri, et al.
Publicado: (2023)

Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor
por: Zhuang, Youwen, et al.
Publicado: (2021)

Serotonin Syndrome: A Syndrome on Syndrome
por: Prakash, Sanjay, et al.
Publicado: (2021)

Furazolidone and Serotonin Syndrome: Is there any Association?
por: Karamanakos, Petros N
Publicado: (2008)

Serotonin syndrome while switching antidepressants
por: Kumar, B. N. Anil, et al.
Publicado: (2011)

Suicide and Serotonin: Making Sense of Evidence
por: Menon, Vikas, et al.
Publicado: (2015)

Encephalitis, myocarditis, and thrombocytopenia after COVID-19 mRNA vaccination: Clinical and pathophysiological considerations
por: Kounis, Nicholas G., et al.
Publicado: (2022)

Spontaneous Major Haemorrhage in COVID-19 Patients: a Proposal for a Pathophysiology-Based Angiographic Treatment
por: Palumbo, Diego, et al.
Publicado: (2021)

Neuromuscular Involvement in COVID-19 Patients
por: Finsterer, Josef
Publicado: (2021)

It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?
por: Ghanei, Mostafa
Publicado: (2021)

Increased Risk of Arrhythmia in COVID-19 Patients: Possible Roles of Both the Disease Pathophysiology and Adverse Drug Reactions
por: Rismanbaf, Ali
Publicado: (2020)

Serotonin syndrome associated with sertraline, trazodone and tramadol abuse
por: Nayyar, Neha
Publicado: (2009)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19
por: Wozniak, Robert J., et al.
Publicado: (2020)

CENTRAL DOPAMINE AND SEROTONIN TURNOVER IN SCHIZOPHRENIA
por: Pandey, R.S., et al.
Publicado: (1987)

Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al.
por: Zeng, Guangting, et al.
Publicado: (2023)

Brainstem clinical and neurophysiological involvement in COVID-19
por: Bocci, Tommaso, et al.
Publicado: (2021)

Author's reply on Pathophysiology of migraine
por: Goadsby, Peter J.
Publicado: (2013)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Diabetes Ketoacidosis and COVID-19: An Insight into the Pathophysiology
por: Ahadiat, Seyed Amirabbas, et al.
Publicado: (2023)

Cardiac involvement in COVID-19: does echocardiography matter?
por: Jorge-Pérez, Pablo, et al.
Publicado: (2021)

Neurological involvement associated with COVID-19 infection in children
por: Chen, Tai-Heng
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4cneods1m4p73m57j53ub12bcs